Entero Therapeutics, Gross Profit Over Time
| ENTO Stock | 0.47 0.02 4.44% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Entero Therapeutics, Performance and Entero Therapeutics, Correlation. Entero |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entero Therapeutics,. If investors know Entero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entero Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.04) | Return On Assets (0.27) | Return On Equity (0.15) |
The market value of Entero Therapeutics, is measured differently than its book value, which is the value of Entero that is recorded on the company's balance sheet. Investors also form their own opinion of Entero Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Entero Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entero Therapeutics,'s market value can be influenced by many factors that don't directly affect Entero Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entero Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Entero Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entero Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Gross Profit Analysis
Compare Entero Therapeutics, and related stocks such as Nextplat Corp, Space Communication, and Cedar Realty Trust Gross Profit Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NXPL | 232 K | 386.1 K | 386.1 K | 386.1 K | 8.2 K | 1.1 M | 1.1 M | 1.2 M | 1 M | 1.2 M | 1.2 M | 1.9 M | 2.5 M | 11.3 M | 11.9 M |
| GTY | 60.6 M | 96.2 M | 71.9 M | 73.1 M | 76.1 M | 87.1 M | 92.5 M | 97.8 M | 112.5 M | 115.7 M | 123.8 M | 133.4 M | 144 M | 162.1 M | 88.1 M |
| SE | 36.2 M | 36.2 M | 36.2 M | 36.2 M | 36.2 M | 107.8 M | 113.1 M | 87.3 M | 14.8 M | 604.9 M | 1.3 B | 3.9 B | 5.2 B | 5.7 B | 6 B |
| SPHR | 377.5 M | 377.5 M | 377.5 M | 377.5 M | 377.5 M | 377.5 M | 193.9 M | 353.8 M | 378.3 M | 645.5 M | 384.7 M | 289.8 M | 231.6 M | 479.1 M | 407.5 M |
Entero Therapeutics, and related stocks such as Nextplat Corp, Space Communication, and Cedar Realty Trust Gross Profit description
Gross profit is a required income statement account that reflects total revenue of Entero Therapeutics, minus its cost of goods sold. It is profit before Entero Therapeutics, operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.My Equities
My Current Equities and Potential Positions
| Entero Therapeutics, | ENTO |
| Classification | Pharmaceutical Products |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
null 0.47
Check out Entero Therapeutics, Performance and Entero Therapeutics, Correlation. To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics, guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Entero Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.